Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 10;11(9):2540-2551.
doi: 10.7150/jca.37604. eCollection 2020.

Application of metabolomics in the diagnosis of breast cancer: a systematic review

Affiliations
Review

Application of metabolomics in the diagnosis of breast cancer: a systematic review

Liqing Yang et al. J Cancer. .

Abstract

Breast cancer (BC) remains the most frequent type of cancer in females worldwide. However, the pathogenesis of BC is still under the cloud, along with the huge challenge of early diagnosis, which is widely acknowledged as the key to a successful therapy. Metabolomics, a newborn innovative technique in recent years, has demonstrated great potential in cancer-related researches. The aim of this review is to look back on clinical and cellular metabolomic studies in the diagnosis of BC over the past decade, and provide a systematic summary of metabolic biomarkers and pathways related to BC diagnosis.

Keywords: Breast Cancer; Diagnosis; Metabolomics.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Systems biology approaches.
Figure 2
Figure 2
Flow chart of the literature search and selection.
Figure 3
Figure 3
Characteristics of clinical studies.
Figure 4
Figure 4
Pathway analysis for clinical significant metabolites.
Figure 5
Figure 5
Characteristics of cellular studies.
Figure 6
Figure 6
Pathway analysis for cellular significant metabolites.
Figure 7
Figure 7
Metabolism in the diagnosis of BC. The red stand for metabolites with hits more than 3, and the green stand for 2-hit frequency metabolites. Abbreviation: G-6-P: glucose-6-phosphate; F-6-P: fructose-6-phosphate; F-1,6-2P: fructose-1, 6-bishosphate; G-3-P: glyceraldehyde-3-phophate; 1,3-DPG: 1,3-diphosphoglyceric acid; 3-PGA: 3-phosphoglycerate; 2-PGA: 2-phosphoglycerate; PEP: phosphoenolpyruvate; DHAP: dihydroxyacetone phosphate; TG: triglyceride; Glycerol-3-P: glycerol-3-phosphate; 1,2-DAG: 1,2-diacylglycerol; PE: phosphatidyl ethanolamine; PC: phosphatidylcholine; CDP DG: cytidine-5'-diphosphate 1,2-diacyl-sn-glycerol; GPC: glycerophosphocholine; MVA: mevalonic acid; HMG CoA: β-hydroxy-β-methylglutaryl- coenzyme A; TCA: tricarboxylic acid.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68:394–424. - PubMed
    1. Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW. Early detection of second breast cancers improves prognosis in breast cancer survivors. Annals of oncology. 2009;20:1505–10. - PubMed
    1. Duffy MJ. Serum tumor markers in breast cancer: Are they of clinical value? Clinical chemistry. 2006;52:345–51. - PubMed
    1. Roganovic D, Djilas D, Vujnovic S, Pavic D, Stojanov D. Breast MRI, digital mammography and breast tomosynthesis: Comparison of three methods for early detection of breast cancer. Bosnian journal of basic medical sciences. 2015;15:64–8. - PMC - PubMed
    1. Armitage EG, Ciborowski M. Applications of metabolomics in cancer studies. Advances in experimental medicine and biology. 2017;965:209–34. - PubMed